29 Jul
2021

Delhi High Court ruling against AstraZeneca could spell trouble for pharma innovators

The latest in a series of unpredictable decisions on the validity of drug species patents could spell trouble for pharma innovators in India

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth